INTRODUCTION
Essential fatty acid (EFA) deficiency is a frequent condition in patients with cholestasis or cystic fibrosis 1, 2, 3 and has various effects on bile production and absorption of dietary fat. 4, 5, 6, 7 Bile salts are essential for bile production, secretory processes and efficient intestinal absorption of dietary fat. In our lab we developed a mouse model to study the effects of EFA deficiency in vivo. 7, 8 Previous studies in this mouse model have shown that EFA deficiency-associated fat malabsorption is not caused by impaired bile formation, like it has been implied earlier in a rat model for EFA deficiency. 6 In EFAdeficient mice an increase in bile flow and biliary secretion was observed. 7 The physiological importance and the underlying mechanism of elevated bile flow and biliary secretion of bile salts during EFA deficiency in mice remains unclear. Bile flow and biliary secretion of bile salts are mainly influenced by the circulation of bile salts from the liver to the intestine, and their reabsorption back to the liver via the portal circulation. This enterohepatic circulation (EHC) of bile salts involves many hepatic and intestinal transporters responsible for the uptake and excretion of bile salts and results in efficient preservation of bile salts within the body. 9 Under physiological conditions, per enterohepatic cycle less than 5 percent of the total amount of bile salts present in the body, i.e. the bile salt pool, is lost via the feces. Under steady state conditions this fraction of bile salts lost is compensated by hepatic bile salt synthesis. 9, 10 Although increased bile flow and biliary secretion have been reported in EFA-deficient mice, it remained unclear how EFA deficiency in mice affects the EHC of bile salts. To address this question, in the current study we measured different steps of the EHC in vivo in EFA-deficient mice by stable isotope dilution technique. We compared the outcomes of the measured bile salt synthesis and pool size by the stable isotope dilution technique with the classical determination of these parameters, namely by determining the expression of the gene encoding cholesterol 7α-hydroxylase (Cyp7a1), which is the rate limiting enzyme in bile salt synthesis. 11, 12 Shortly, by stable isotope dilution technique, different parameters of the EHC (synthesis, pool size, fractional turnover rate, ileal reabsorption and cycling time) were determined in vivo by means of the intravenous injection of a stably labeled bile salt and subsequent determination of plasma enrichment of the label. This method, known as the stable isotope dilution technique, has been developed and validated previously in our lab to measure bile salt kinetics in vivo without interrupting the normal EHC. 9, 10 We have chosen to inject the stably labeled cholate ( 2 H 4 -cholate), as this is the primary and most abundant bile salt in humans and rodents;
total bile acid pool consists of 30% to 50% and 50% to 80% of cholate (CA) in humans and rodents, respectively. 10 To confirm our in vivo findings, we additionally measured expression of relevant intestinal genes in the EHC of bile salt synthesis in small intestinal model for EFA deficiency (post confluent Caco-2 cells) upon stimulation with chenodeoxycholic acid (CDCA) and GW4064 compound, both potent agonists of FXR. Elucidating the mechanism behind the elevated bile flow during EFA deficiency, might help to understanding and treat fat malabsorption during EFA deficiency. Our study demonstrates that increased secretion of bile salts during EFA deficiency in mice is associated with enhanced bile salts synthesis, despite increased reabsorption of bile salts in the intestine. Our results clearly show that increased bile production during EFA deficiency cannot be contributed exclusively to FXR, but that other factors must contribute as well. In vivo and in vitro data show impaired transcriptional regulation of genes involved in intestinal regulation of bile salt homeostasis under EFA-deficient conditions. This suggests an impaired intestinal feedback mechanism of bile salt synthesis during EFA deficiency.
MATERIAL AND METHODS

Mice and housing
Male wild type mice (~25 g) on a free virus breed (FVB) background were obtained from Harlan (Horst, the Netherlands) and were housed in a light-and temperature-controlled facility. Tap water and food were allowed ad libitum. In a separate experiment, where we aimed to determine whether the effects of EFA deficiency on the EHC of bile salts were FXR-dependent, we used male homozygous (Fxr -/-) and wild type (Fxr +/+ ) mice on mixed (C57BL/6Jx129/OlaHsd) background of 25-40 g. These mice were generated previously by Deltagen, Inc. (Redwood City, CA) and bred at the animal facility of the University of Groningen. 9 Food intake and fecal excretion were monitored during a 72h period at the end of the experiment. For clarity reasons, mice fed the EFA-deficient or control diet (on FVB background) will be mentioned as EFA-deficient or control mice. Fxr +/+ and Fxr -/-mice fed the EFA-deficient or control diet will also be entitled as EFA-deficient or control, respectively, with the genotype indicated in addition. The experimental protocol was approved by the Ethics Committee for Animal Experiments, Faculty of Medical Sciences, University of Groningen, Netherlands.
Experimental diets
As in our previous studies, we used high-fat (humanized) EFA-deficient (#4141.08) and EFA-sufficient (control, #4141.07) diets (16 wt% and 34 energy% fat), which were custom synthesized by Arie Blok BV (Woerden, the Netherlands. 7, 8 Essentially, unsaturated fatty acids in EFA-sufficient diet were replaced by saturated fatty acid in EFA-deficient diet; EFA-deficient diet was particularly reduced in linoleic acid (essential fatty acid) concentration. In detail, EFA-deficient diet contained 64 mol% palmitic acid (C16:0), 18 mol% stearic acid (C18:0), 13 mol% oleic acid (C18:1ω-9) and 5 mol% linoleic acid (C18:2ω-6). Isocaloric EFA-sufficient diet contained 36 mol% C16:0, 5 mol% C18:0, 31 mol% C18:1ω-9 and 29 mol% C18:2ω-6. Fatty acid contents of the diets were analyzed by extracting, hydrolyzing and methylating total dietary fatty acids. Subsequent separation and quantification of fatty acid methyl esters was performed by gas chromatography as described previously. 
Methods
Induction of EFA deficiency
Mice were fed the EFA-deficient or control diet for 8 weeks, consistent with previous studies in EFA-deficient mice. 7, 8, 14 After 8 weeks of EFA-deficient or control diet, mice underwent a 72h fat balance test, bile cannulation and stable isotope dilution test (details see below). Afterwards, the mice were anesthetized and sacrificed through cardiac puncture. The marker of EFA deficiency, triene/tetraene ratio (C20:3ω-9/C20:4ω-6), was determined in erythrocyte lipids as described previously. 7, 8 Protocol for induction of EFA deficiency in Caco-2 cells is described in section "Stimulation of differentiating EFAdeficient and control Caco-2 cells to CDCA and GW4064".
Fat absorption
Absorption of major dietary fatty acids was assessed by measuring food intake and collecting feces for 72h. Net amount of fat absorbed was calculated by subtracting the fecal excretion of the major fatty acids (stearate, palmitate, oleate and linoleic acid) from the amount of fatty acids ingested, determined by gas chromatography. 7 
Stable isotope dilution
The stable isotope dilution test was performed as previously described, slightly modified. 10 Three days prior to the end of the experiment, after the fat absorption test was completed, 400 μg of 2 H 4 -cholate in a solution of 0.5% NaHCO 3 in PBS was slowly injected intravenously under isoflurane anesthesia. At different time points (12, 24, 36 , 48 and 60h) blood samples of 75 μl were collected by orbital punction under isoflurane anesthesia to determine the isotope enrichment in plasma. Blood, collected in microhematocrit tubes containing heparin, was centrifuged (4,000 rpm for 10 min) and plasma was stored at -20°C until further analysis. Samples used for baseline isotope abundance measurements were obtained by orbital puncture from a separate group of mice.
Bile collection
After the mice were anesthesized with Hypnorm/Diazepam mixture, the bile duct was cannulated during 30 minutes and bile flow was determined gravimetrically (1 g/ml). During the cannulation, body temperature was maintained by placing the mice in a humidified incubator (37°C). 9 
Sample collection
The small intestine was excised, flushed with ice-cold PBS and the last part (terminal ileum) was harvested for gene (mRNA) expression. The livers were excised and weighed. Subsequently, small pieces were cut out for mRNA and biochemical analysis.
Prior to storage at -80°C, tissues were snap-frozen in liquid nitrogen. 
Cell culture
Analytical methods
Biliary bile salts and lipids
Bile salt concentration in bile was determined by an enzymatic fluorimetric assay. 16 Biliary phospholipids and cholesterol were determined as described by Kuipers et al.
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Gas chromatography Fatty acids in erythrocytes, food and feces of the mice, and fatty acids in Caco-2 cells were analyzed by extracting, hydrolyzing and methylating total dietary fatty acids as described by Muskiet et al. 13 Subsequent separation and quantification of fatty acid methyl esters was performed by gas chromatography. 7 Bile salt composition of bile samples was determined by capillary gas chromatography. 9 
Preparation of plasma samples for isotope analysis and gas-liquid chromatographyelectron capture negative chemical ionization mass spectrometry (GLC-MS)
Plasma and bile samples were prepared for GLC-MS analysis on a Finnigan SSQ7000 Quadrupole GC-MS machine as described previously by Stellaard et al. 18 Isotope dilution technique has been described in detail by Hulzebos et al. 10 Shortly, enrichment of 2 H 4 -cholate in plasma was determined as the increase of the M 4 -/M 0 -cholate relative to baseline measurements and is expressed as the natural logarithm of atom percent excess (ln APE). From the decay curve of ln APE (calculated by linear regression analysis), daily fractional turnover rate (FTR; equals the slope of the regression line) and pool size ((administered amount of label x isotopic purity x 100) / e intercept of the y-axis of the ln APE curve ) of cholate were calculated. Subsequently, cholate synthesis rate was calculated by multiplying pool size and FTR. In addition, the amount of cholate reabsorbed per day, the cycling time and biliary secretion rate of cholate were calculated as described previously. 9, 10 Cholate was the most abundant bile acid in the bile salt pool of both EFA- deficient (~58%) and control mice (~58%). Therefore, we assumed that the parameters calculated for cholate were representative for the complete bile salt pool.
Measurement of mRNA expression by quantitative PCR (Taqman)
mRNA expression of hepatic genes involved in bile salt synthesis, hepatic transporter genes (for bile salts, cholesterol and phospholipids), ileal genes implicated in enterohepatic circulation of bile salts and FXR-target genes in Caco-2 cells were determined by quantitative PCR as described previously. 19 PCR results in the liver were normalized to the RNA expression of the housekeeping gene 18s, in ileum to the housekeeping gene -actin and in Caco-2 cells to GAPDH. The sequences of the primers and probes are listed in Table 1 .
Heuman index
The Heuman index is a numeric representation of hydrophilic-hydrophobic balance, corresponding with the ability of bile acids to solubilize dietary fats. For determination of the hydrophobicity of the bile salt pool, we calculated the Heuman index after quantification of major biliary bile salts by gas chromatography. 
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Statistical analysis
RESULTS
Body weight and food intake were not different between EFA-deficient and control FVB mice (Table 2 ). Consistent to our previous findings in EFA-deficient mice, liver weight was higher in EFA-deficient mice compared with controls ( Bile salts are the natural ligands of FXR and can activate the FXR in the ileum. In ileum, FXR activated by the bile salts induces release of fibroblast growth factor 15 (Fgf15; homologue to human FGF19), which is transported to the liver to inhibit the bile salts synthesis. 23 Fgf15 has been characterized as important component of the gut-liver signaling pathway that regulates the bile salt synthesis. Similar to EFA-deficient and control FVB mice, after 8 weeks of diet there was no difference in body weight or food intake between EFA-deficient Fxr -/-or Fxr +/+ mice compared with mice of the same genotype on control diet (Table 3) . Liver weight was higher in EFA-deficient Fxr -/-mice compared with the same mice on control diet (Table 3 ). In Fxr +/+ mice this difference did not reach the significant value ( Biliary secretion rates of bile salts and phospholipids were two-to threefold higher in EFA-deficient compared with the control FVB mice (each p<0.05) ( Table 4) . To determine if EFA deficiency results in altered composition of bile salt pool, we determined biliary bile salt composition and calculated its hydrophobicity, using the Heuman index number. 20 EFA deficiency did not result in major changes in bile salt composition (Figure 1 ) or in the Heuman index (-0.20 ± -0.06 in EFA-deficient versus -0.21 ± -0.03 in control mice, NS). In order to investigate if enhanced bile flow in EFA-deficient mice was dependent of biliary bile salt secretion, we plotted the bile flow (y-axis) against the biliary bile salt output (x-axis) (data not shown). There is a classical linear relationship between these two parameters, indicating that EFA deficiency in mice does not affect the normal bile formation. Increased bile flow during EFA deficiency is most likely caused by the increased bile salt output. 
mRNA expression of genes involved in EHC in EFA-deficient mice
By means of quantitative PCR we determined the mRNA expression of hepatic and ileal genes implicated to be important in bile salt homeostasis or bile flow ( Figure 3 ). EFA deficiency did not have a major effect on the mRNA expression of the gene encoding the rate-limiting enzyme in bile salt synthesis, namely Cyp7a1 (0.62 ± 0.31 versus 1.24 ± 0.59 in control mice, NS) (Figure 3a) . The mRNA expression of Cyp8b1, which encodes the gene of the enzyme catalyzing the cholic acid synthesis in the liver and is feedbackinhibited by bile salts, was significantly increased in EFA-deficient mice (2.23 ± 0.8 versus 1.2 ± 0.3 in control mice, p<0.05) (Figure 3a) . However, EFA deficiency did not have a major effect on the mRNA expression of other genes involved in hepatic bile salt synthesis (Fxr, Shp, Fgfr4 and Cyp27a1) (Figure 3a) . When activated by bile salts in the intestine, FXR activates the mRNA expression and release of Fgf15, which subsequently travels to the liver via the portal circulation in order to inhibit the hepatic bile salt synthesis. 23 We observed a decrease in mRNA expression of Fgf15 gene in the terminal ileum of EFA-deficient (FVB) mice, despite an increased bile salt synthesis and secretion (Figure 3b ). These data are confirmed by measurement of Fgf15 in Fxr +/+ mice on mixed background (C57BL/6Jx129/OlaHsd); in EFA-deficient Fxr +/+ mice, Fgf15 mRNA expression was significantly lower than in Fxr +/+ mice on control diet (Figure 4b ). These data indicate an effect of the EFA deficiency on Fgf15 mRNA expression, independent of the genetic background of the mice. mRNA of Fgf15 was almost absent in Fxr -/-mice on both EFA-deficient and control diet (Figure 4b ), demonstrating that Fgf15 mRNA expression is regulated by the FXR, as reported previously. 23 The mRNA expression of FXR itself and genes encoding the ileal bile salt-transporters (Ostα, Ostβ, Ibabp and Asbt) was not significantly affected by EFA deficiency in mice (Figure 3b ).
In order to evaluate whether the expression of hepatic transporters of bile salts, phospholipids and cholesterol correlates with the observed increase in bile flow in EFAdeficient mice, we measured the mRNA expression of genes encoding the hepatic transporters (Figure 3c ). However, EFA deficiency did not affect the mRNA expression of the majority of the genes, except for a decrease in Mrp3 (basolateral organic anion transporter) (Figure 3c ).
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Figure 3 mRNA expression of genes involved in (a) hepatic bile salt synthesis, (b) ileal bile salt transport and (c) hepatic transport of bile salts (BS), phospholipids (PL) and cholesterol (CL). Data represented means ± SD of n=6 mice per group. *p<0.05 is the significant difference between EFAdeficient (white bars) and control (black bars) mice.
EFA deficiency associated increase in bile flow is FXR-independent
To study to what extent alterations in bile production upon EFA deficiency were FXRdependent, we determined the bile flow by bile cannulation in 
CDCA and GW4064 stimulation of EFA-deficient Caco-2 cells
To study direct effects of EFA deficiency on FXR activation, in vitro experiments were performed in post confluent Caco-2 cells treated with CDCA and GW4064, both very potent (and the latter one highly specific) FXR agonists. Upon confluence Caco-2 cells spontaneously differentiate and develop small intestinal features, as indicated by the expression of enterocyte markers lactase and sucrose-isomaltase. 25 As expected, after 8-10 days in EFA-deficient medium Caco-2 cells showed clear signs of EFA deficiency as indicated by significantly lower levels of linoleic acid (Figure 5a ) and ω-6 family of fatty acids (Figure 5b) (Figure 5c ). FGF19 mRNA expression was further increased in control Caco-2 cells upon stimulation with higher CDCA concentration of 250 µM (resembling the concentrations bile salts reabsorbed during EFA deficiency in mice) (Figure 5c ). This effect was also seen in EFA-deficient cells after treatment with 250 µM CDCA (Figure 5c ). Treatment with GW4064 (1 µM) did not increase mRNA expression of FGF19 in either control or EFA-deficient Caco-2 cells (Figure 5c ). Although there was no significant difference in FGF19 mRNA expression between EFA-deficient and control cells, EFA-deficient cells seemed to have slightly lower mRNA expression of FGF19 compared to control cells in all conditions. Both CDCA (lower and higher concentrations) and GW4064 (1 µM) significantly induced the mRNA expression of FXR target-gene IBABP in control Caco-2 cells (Figure 5d ). This effect was almost completely absent in EFA-deficient Caco-2 cells (Figure 5c 
DISCUSSION
We determined the effects of EFA deficiency on bile flow and kinetic parameters of the EHC of bile salts in mice, since we previously observed an increased bile flow and biliary bile salt secretion in combination with fat malabsorption. The mechanism of altered bile production during EFA deficiency in mice had remained unclear. Insight into this mechanism will hopefully allow us to design new strategies to interpret and treat fat malabsorption, specifically in EFA deficiency. Our data show that EFA deficiency in mice increases bile salt synthesis and intestinal reabsorption, resulting in a profoundly increased bile salt pool size, biliary bile salt secretion and bile flow. In mice in which FXR was genetically inactivated, EFA deficiency resulted in similar changes as in wild type mice, regarding biliary secretion of bile salts and bile flow. This finding indicates that the changes in bile production during EFA deficiency were essentially FXR-independent. Finally, our data suggest that the increased bile salt synthesis may be related to downregulation of ileal Fgf15 gene expression, interfering with the negative feedback regulation of hepatic bile salt synthesis. Consistent with our previous findings, after 8 weeks of EFA-deficient diet, mice were clearly EFA-deficient. Although previous studies in EFA-deficient mice reported slightly increased cholate and slightly decreased β-muricholate fraction in bile, in present study EFA deficiency in mice was not associated with major changes in biliary bile salt composition. 7 These data underscore our previous findings that neither a decrease in biliary flow, nor major alterations in bile composition are the cause of fat malabsorption in EFA-deficient mice. Theoretically, increased biliary bile salt secretion during EFA deficiency could act as a compensatory mechanism for reduced absorption of fat. This is, however, conflicting with studies in rats where fat absorption is similar to that in mice (80-84%), despite a decreased biliary secretion. 6, 26 We cannot exclude that the proposed compensatory mechanism during EFA deficiency is differentially regulated among the different species. Enhanced bile flow was associated with increased biliary output of bile salts and phospholipids. The ratio between bile salts and lipids was similar between EFA-deficient and control mice (data not shown), suggesting unaltered coupling of bile salts to lipids in bile upon EFA deficiency. Since the mRNA expression of the hepatic genes encoding transporters for cholesterol (Abcg5/Abcg8) and phospholipids (Mdr2) was not significantly changed upon EFA deficiency in mice, it is tempting to assume that the increased output of lipids in EFA deficiency was entirely based on the increased bile flow. Increased bile salt secretion was not associated with altered expression of several genes encoding hepatic bile salts transporters (Bsep, Ntcp, Mrp2 and Oatp1), possibly due to the fact that the expression of the transporters is not rate limiting factor for the increased secretion rate of bile salts. 27 Moreover, bile salt transporters are localized along the hepatic acinus, while the bile salt transport is localized mainly at the periportal zone. 28 This implies that the number of hepatocytes, rather than the gene expression of transporters, is the rate limiting factor during the altered bile salt secretion rate in mice. Whole body kinetics of cholate, 10 clearly demonstrated that the increased biliary secretion of bile salts is associated with increased bile salt synthesis. The mRNA expression of Cyp7a1 gene was not affected by EFA deficiency. However, studies on bile salt formation under different conditions have shown that altered synthesis of bile salts is not always correlated to changes in Cyp7a1 mRNA expression. 29, 30 Previous studies in EFA-deficient mice revealed unaltered mRNA expression of Cyp7a1. 7 Since
Cyp7a1 has been shown to have a remarkable circadian mRNA expression, with highest levels during the night, we cannot exclude that the differences in expression between EFA-deficient and control mice would have been different during the night. 31 Increased bile salt synthesis was accompanied by the increased mRNA expression of Cyp8b1 gene, encoding the enzyme responsible for the synthesis of cholic acid and control over 4 CHAPTER Figure 5 The the ratio of cholic acid over chenodeoxycholic acid in the bile. 32 However, as stated previously, our data on biliary composition in EFA-deficient mice do not show major differences in the concentrations cholic acid and chenodeoxycholic acid in bile compared with control animals. This suggests that the increased Cyp8b1 mRNA gene expression does not lead to major physiological changes in EFA-deficient mice. Unlike Cyp7a1, Cyp8b1 was shown to have the highest mRNA expression during the day; this could be an explanation for the detected difference in Cyp8b1, but not in Cyp7a1, mRNA expression between EFA-deficient and control mice. 33 Our findings on mRNA gene expression measurements of Cyp7a1 and Cyp8b1 underscore the importance of physiological measurements, along with mRNA expression of genes in order to properly study the EHC of bile salts in vivo. The expression of other relevant genes involved in bile salt synthesis (Shp, Cyp27a1) remained similar in EFA-deficient compared with control mice, while the bile salt synthesis was increased. Stable isotope dilution study revealed an enlargement of the bile salt pool in EFAdeficient mice, suggesting an impaired feedback inhibition of the hepatic bile salt synthesis. The FTR, representing the fraction of the pool renewed each day, was decreased in EFA-deficient mice, while the reabsorption of the bile salts in the intestine was increased. Normally, the enhanced bile salt reabsorption is expected to activate the FXR in the ileum and thereby induce the release of Fgf15 into the portal circulation, which in turn eventually inhibits the bile salts synthesis in the liver. 23, 34 To our surprise, we found a decreased mRNA expression of Fgf15 gene in EFA-deficient mice, indicating a disruption in the intestinal feedback regulation of bile salt synthesis. We realize that the experimental setting we performed in this study does not allow for direct evidence demonstrating that the increased bile salts synthesis in EFA-deficient mice is directly related to, or the result of, the lower plasma concentration of Fgf15. So far, it has not been possible to determine the concentration of Fgf15 in the (portal) plasma of EFAdeficient mice and all of the studies performed so far on the role of Fgf15 in bile salt metabolism in mice are based on the ileal mRNA expression of this gene. In order to determine to what extent the effects of EFA deficiency on bile production were FXR-dependent, we repeated key experiments in mice lacking FXR and their wild type littermates. The rationale behind this was based on two findings; first, during the past decade FXR has been shown to play a crucial role in controlling bile acid homeostasis, 41, 42 and second, our data on bile salt kinetics during EFA deficiency in mice corresponded to a certain extent with changes in bile salt kinetics upon FXRinactivation observed by Kok et al. 9 Similar to the situation in Fxr -/-mice, EFA-deficient mice showed enhanced pool size, increased synthesis and enhanced bile salt reabsorption of bile salts and similar cycling time compared with control mice. Despite the similarities in the separate effects of EFA deficiency and FXR deficiency in mice on bile salt kinetics, we showed that when combined, the effects of EFA deficiency with additional FXR-inactivation on bile flow and biliary secretion are similar to the effects of EFA deficiency alone. This indicates that when combined, the effects of EFA deficiency on bile flow and biliary secretion rate of bile salts are independent of FXR. Kok et al. proposed that the defective negative feedback inhibition of hepatic cholate synthesis was the consequence of the absence of FXR in vivo. The underlying mechanism, however, remained unclear. 9 In our study we show that the defective negative feedback inhibition of bile salt synthesis in EFA-deficient mice is probably due to reduced Fgf15 expression. In Figure 6 , we propose the mechanism responsible for altered bile salt kinetics during EFA deficiency in mice. The increased bile salt secretion is consistent with increased synthesis, larger pool size and enhanced ileal reabsorption, without affecting the cycling time of bile salts. We suggest that the preserved bile salt synthesis is due to an intestinal (intracellular) defect leading to a decreased, instead of increased, expression of Fgf15. However, the exact intracellular effects of EFA deficiency on bile salt activation of FXR and subsequent regulation of the Fgf15 gene expression and its secretion remain to be elucidated. EFA deficiency can possibly lead to increased cellular permeability and reduced membrane integrity in the enterocytes, resulting in impaired uptake of bile salts in the ileal enterocytes. To our knowledge, studies on cellular permeability in the enterocytes during EFA deficiency have not been performed yet.
Further studies of the effects of EFA deficiency on cellular function will hopefully help us understand how this correlates to the intestinal regulation of the negative feedback synthesis of bile salts.
In conclusion, our study demonstrates that EFA deficiency in mice clearly affects bile salt metabolism at several steps during the EHC of bile salts. We show, indirectly, that reduced intestinal function is at least partly involved in EFA deficiency associated alterations in the gut-liver signaling during the bile salt homeostasis. Further studies are required to determine if adaptations in bile homeostasis can allow for improved fat absorption during EFA deficiency.
